Phases of Clinical Trials This video explains the three main phases of clinical trials. Clinical trials to test new cancer treatments involve a series of steps, called phases.
The intent is to provide detailed knowledge of the project management practices, skills and tools that will make the difference between a successful clinical trial and one that does not meet its goals. By the end of the course, participants should be able to do the following: Understand the overall drug development process and the unique aspects of Phase 0 through Phase 4 Apply project management best practices to clinical trials Manage a development project team and recognize team needs and leadership skills required for different stages of the drug development process Refine the target product profile and position the drug for future submission, approval and launch Understand GCP guidelines, FDA, EMA regulations and ICH guidelines Understand and manage the challenges of clinical trials outside the USA Develop accurate clinical trial timelines and budgets Achieve high quality clinical data and optimize study logistics Manage clinical supplies in your project plan Manage adverse event reporting and protocol deviations Prevent and manage fraud and study misconduct Testimonials "The Course Director is highly knowledgeable and very skilled in teaching and getting all participants involved.
The course is illustrated with many practical anecdotes of real life experiences in the pharma world. The course also includes exercises that are very instructive. This three day course was really worthwhile.
I would recommend this course to others.
It provides the "language" the proper lingo to articulate the management of clinical studies. Break our sessions were really good — lots of interaction. Good ideas, excellent networking opportunity! I will suggest to my peers to attend this course since it can be applied at any level of pharma.
I got far more information out of this course than I anticipated!
Great speaker, great content! Frequently Asked Questions If I have been managing clinical trials for some time, will this course be redundant for me? It could be viewed as a refresher. A wide variety of topics are covered, from managing time, scope and budget of a trial to the regulations for trials in the US, EU and Japan as well as team skills to manage staff involved in your trial.
Every company manages studies differently, so there is a great deal to learn from participants as well as the instructor.
Will this course be useful for someone involved only with veterinary products? Although the process of approval for new animal drugs is similar to human, there are enough differences that this course may not be useful if someone is involved only with veterinary products.
Is the course geared towards a specific therapeutic area? The clinical trial management information is not specific for any therapeutic are, but can be utilized for all areas, in general. Some of the case studies and break-out sessions focus on a specific therapeutic area, but only for learning purposes.
Are device studies covered in this course? No, device studies are not covered in detail, just in passing.
CfPIE is committed to enhancing the ongoing professional development of regulatory affairs professionals and others through appropriate regulatory affairs learning activities and programs. Click here for the list of courses reviewed and approved by RAPS.
Each person attending a course will be asked to set up an Attendee Profile Account during the registration process. Accounts are a new feature on our website. Creating an Account helps you view your order history and manage your training programs.
Attendee IDs allow you to register on behalf of others quickly and easily. Instructions are provided when checkout is complete. Cannot be combined with other discounts or offers. CfPIE offers more than class sessions annually across 80 course titles in multiple formats, such as classroom, on-site and certification programs.CONFERENCE INTRODUCTION: With four-out-of-five clinical trials failing to meet original recruitment targets, new approaches are needed.
Patients with chronic conditions or life-threatening diseases are often looking for a solution, a treatment that may help improve their quality of life or extend their life. - Abbott's new DRG Invisible Trial System brings an intuitive, wireless approach to the temporary evaluation giving patients the full benefits of DRG therapy prior to permanent implant.
Phase IIIb - IV; Real World and Late Phase; Functional Service Provider. Syneos Health TM consulting practitioners span the entire product development and delivery continuum, adding high-value counsel and recommendations that make for more successful clinical development and brand launch success.
Brand Commercialization. The A1 suffix is typically seen as part of an application identification number or grant number and “A1” is often used to refer to a new, renewal, or revision application that is amended and resubmitted after the review of a previous application with the same project number.
Clinical trial-related “routine patient costs” that health insurers must cover includes “all items and services consistent with the coverage provided in the plan (or coverage) that is typically covered for a qualified individual who is not enrolled in a clinical trial.”.
Early Clinical Development; Phase IIb/III Study Delivery; Global Laboratory Services; Have a concern related to IQVIA business operations? Please email the Business Ethics Office.
Search ; Clinical trial Design. Let us help you optimize you clinical trial design for quality and performance. Video Data-driven Trial Execution.